Press release
GM1 Gangliosidosis Treatment Market
GM1 Gangliosidosis Treatment Market Size, Share, Industry, Forecast and Outlook (2023-2030)
Market Overview:
The global GM1 gangliosidosis treatment market is anticipated to experience significant growth due to factors such as rising lysosomal storage disorders, increased research and development activities, and government investments in pharmaceuticals and biotechnology.
Market Dynamics:
Drivers:
Government Investments and Research: Increasing emphasis on GM1 gangliosidosis treatment through government investments in developing economies is driving the adoption of gene therapy and enhancing the market's growth.
Advancements in Clinical Outcomes: Positive outcomes from clinical trials and advancements in treatment methodologies are contributing to the market's expansion.
Challenges:
Limitations in Therapies: Limitations related to therapies, such as the challenges associated with gene therapy and the limitations of glucosylceramide synthase inhibition, pose challenges in treating GM1 gangliosidosis effectively.
Request for Sample: https://www.datamintelligence.com/download-sample/gm1-gangliosidosis-treatment-market
Segmentation Analysis:
Market Segments: The GM1 gangliosidosis treatment market is segmented based on type, treatment, end-user, and region, with gene therapy showing promising advantages for treatment.
Geographical Share:
North America: Dominates the market, particularly the United States, due to the region's strong presence of major players, increasing healthcare infrastructure investment, and research studies in GM1 gangliosidosis treatment.
COVID-19 Impact:
Supply Chain Disruptions: The COVID-19 pandemic caused significant disruptions in the medical device sector, impacting the demand for GM1 gangliosidosis treatment. Pharmaceutical plants reduced or suspended production due to decreased demand and supply chain disruptions.
Labor Shortages and Safety Measures: Labor shortages and stringent safety measures in pharmaceutical plants led to reduced workforce on-site, impacting crucial activities throughout the pandemic.
Russia-Ukraine War Impact:
The conflict has disrupted clinical trials and therapeutic developments, potentially leading to delays, loss of business continuity, and compliance issues for therapies already in the market. The shift of clinical trials from affected regions to other parts of Europe is being considered.
Key Developments:
Companies like Passage Bio, Lysogene, Sio Gene Therapies, Inc., among others, have released promising safety, biomarker, and clinical development data from their respective clinical trials, showcasing advancements in GM1 gangliosidosis treatment.
Key Companies:
Major players in the GM1 gangliosidosis treatment market include Passage Bio, Lysogene, Sio Gene Therapies, Inc., BioStrategies LC, Sanofi, AZAFAROS, Dorphan S.A., Idorsia Pharmaceuticals Ltd, SphinCS GmbH, and Viatris Inc.
The market for GM1 gangliosidosis treatment continues to evolve with promising advancements in gene therapy and ongoing research and development. However, challenges related to therapeutic limitations and external factors such as the COVID-19 pandemic and geopolitical disruptions pose significant hurdles for the market's growth and stability.
Related Reports:
https://www.datamintelligence.com/download-sample/alpha-mannosidosis-treatment-market
https://www.datamintelligence.com/download-sample/alpha-mannosidosis-treatment-market
https://www.datamintelligence.com/download-sample/mastocytosis-treatment-market
Media Contact
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com/
About DataM Intelligence
DataM Intelligence 4Market Research is a Market Research firm that provides end-to-end business solutions to organizations from Research to Consulting. We at DataM Intelligence leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of Syndicate Reports & and; Customized Reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release GM1 Gangliosidosis Treatment Market here
News-ID: 3286490 • Views: …
More Releases from DataM Intelligence 4market Research LLP
Nitrile Butadiene Rubber Market Growing at 5.55% CAGR Driven by Automotive & Hea …
The Nitrile Butadiene Rubber Market reached USD 2.35 billion in 2024 and is expected to reach USD 3.62 billion by 2032, growing at a CAGR of 5.55% during the forecast period 2025-2032.
Market growth is fueled by surging demand for durable, oil-resistant materials in automotive seals, hoses, and gaskets amid rising vehicle production, expanding applications in healthcare gloves post-pandemic, and increasing use in industrial cables and footwear. Key drivers include superior…
Out of Autoclave Prepreg Market Set for Robust Growth Through 2032 Driven by Aer …
The Out of Autoclave Prepreg Market demonstrated strong growth in 2024 and is projected to witness significant expansion by 2032, registering a robust compound annual growth rate during the forecast period 2025 to 2032
Market growth is fueled by surging demand for lightweight, high-performance composites in aerospace and automotive sectors, advancements in resin systems enabling lower-cost processing outside expensive autoclaves, and expanding applications in wind energy and sporting goods. Key…
Japan AI Culinary Robots Market Poised for 8.77% CAGR Amid Labor Shortages
The Japan AI Culinary Robots Market reached US$ 470.01 million in 2023 and is expected to reach US$ 921.02 million by 2031, growing at a CAGR of 8.77% from 2024 to 2031. This robust growth is driven by acute labor shortages in the food service industry amid Japan's declining workforce, rising minimum wages pushing automation adoption, increasing demand for consistent quality and hygiene in commercial kitchens, advancements in AI vision…
Japan Software as a Medical Device Market Poised for 17.3% CAGR Amid AI & Digita …
The Japan AI Culinary Robots Market reached US$ 470.01 million in 2023 and is expected to reach US$ 921.02 million by 2031, growing at a CAGR of 8.77% from 2024 to 2031. This robust growth is driven by acute labor shortages in the food service industry amid Japan's declining workforce, rising minimum wages pushing automation adoption, increasing demand for consistent quality and hygiene in commercial kitchens, advancements in AI vision…
More Releases for GM1
GM1 Gangliosidosis Market to Witness Significant Growth Driven by Gene Therapy I …
Pune, India, December 12, 2025 - The GM1 Gangliosidosis Market is set to expand rapidly as breakthroughs in gene therapy and growing governmental as well as private investments reshape the treatment landscape. GM1 gangliosidosis is a rare, inherited lysosomal storage disorder resulting from GLB1 gene mutations that cause a deficiency of β-galactosidase, leading to severe neurodegeneration. With no approved curative therapy currently available, biotech innovators are intensifying efforts to develop…
GM1 Gangliosidosis Market Expected to Reach USD 1.6 Billion by 2034
GM1 gangliosidosis is a rare, inherited lysosomal storage disorder caused by mutations in the GLB1 gene, leading to a deficiency of the β-galactosidase enzyme. This results in the accumulation of GM1 gangliosides in cells, primarily affecting the central nervous system. The disease is classified into infantile, juvenile, and adult-onset forms, with infantile GM1 being the most severe and often fatal in early childhood.
Download Full PDF Sample Copy of Market Report…
GM1 Gangliosidosis Market Massive Growth opportunity Ahead
GM1 Gangliosidosis Market Outlook 2024-2034: Expanding Research, Orphan Drug Approvals, and Regional Growth
Introduction
GM1 Gangliosidosis is an ultra-rare, inherited lysosomal storage disorder caused by mutations in the GLB1 gene, leading to progressive neurodegeneration. Patients experience a range of symptoms-from developmental delays and skeletal abnormalities to severe motor dysfunction and premature mortality. With no approved curative therapy to date, treatment options remain largely supportive.
However, the last decade has witnessed a surge in…
GM1 Gangliosidosis Market Size And Global Industry Forecast 2034
Introduction
The GM1 Gangliosidosis Market is gaining attention as advancements in genetic research and rare disease drug development open new possibilities for this ultra-rare lysosomal storage disorder. GM1 gangliosidosis is caused by mutations in the GLB1 gene, leading to a deficiency of the β-galactosidase enzyme and progressive neurodegeneration. With no approved curative treatments currently available, ongoing innovation in gene therapy, enzyme replacement therapy (ERT), and small molecule chaperones is fueling significant…
GM1 Gangliosidosis Treatment Market Analysis, Status and Business Outlook 2021 t …
Dec 07, 2021 (Market Intelligence Data) --Global GM1 Gangliosidosis Treatment Market Size, Status, and Forecast 2021-2026. In-depth research accumulated to offer Latest insights about acute features of the global GM1 Gangliosidosis Treatment market. This report provides a detailed overview of key factors in the GM1 Gangliosidosis Treatment Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development. The impact of the COVID-19 outbreak on the industry was…
GM1 Gangliosidosis Treatment Market Higher Mortality Rates by 2027
"Industry analysis is a crucial step in the current competitive market space that helps identify the right target customers and accordingly provide tailored solutions for their business needs. Every aspect and unique challenges put up by the particular industry are carefully taken into consideration while formulating these solutions. It also takes into consideration various government reforms, competitive environment, customer behavior, existing and upcoming business models, and ever-evolving technological developments. Industry…
